Literature DB >> 2804036

Ocular melanoma.

A B Tullo, C L Dodd, J L Noble, S Owens, H Rao.   

Abstract

Entities:  

Mesh：

Year:  1989        PMID： 2804036      PMCID： PMC1041877          DOI： 10.1136/bjo.73.9.771

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN： 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  5 in total

1.  Radioimmunoscintigraphy of ocular melanoma with 99mTc labelled cutaneous melanoma antibody fragments.

Authors:  J Bomanji; J L Hungerford; M Granowska; K E Britton
Journal:  Br J Ophthalmol       Date:  1987-09       Impact factor: 4.638

2.  Characterisation of ocular melanoma with cutaneous melanoma antibodies.

Authors:  J Bomanji; A Garner; J Prasad; D M Albert; J L Hungerford; M Granowska; K E Britton
Journal:  Br J Ophthalmol       Date:  1987-09       Impact factor: 4.638

3.  Dosimetry of iodine-131 ethiodol in the treatment of hepatoma.

Authors:  M T Madsen; C H Park; M L Thakur
Journal:  J Nucl Med       Date:  1988-06       Impact factor: 10.057

4.  Uptake of 99mTc labelled (Fab')2 fragments of monoclonal antibody 225.28S by a benign ocular naevus.

Authors:  J Bomanji; J L Hungerford; M Granowska; K E Britton
Journal:  Eur J Nucl Med       Date:  1988

5.  Monoclonal antibodies to uveal melanoma.

Authors:  B E Damato; A M Campbell; B J McGuire; W R Lee; W S Foulds
Journal:  Eye (Lond)       Date:  1987       Impact factor: 3.775
  5 in total
  3 in total

1.  Immunoscintigraphy for ocular melanoma: a reliable diagnostic technique?

Authors:  K U Loeffler; P Bräutigam; J C Simon; S R Althauser; C Wuttig; H Witschel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-02       Impact factor: 3.117

2.  Ocular melanoma.

Authors:  D F Schaling; J A Oosterhuis; E K Pauwels
Journal:  Br J Ophthalmol       Date:  1990-04       Impact factor: 4.638

3.  Radioimmunoscintigraphy and immunohistochemistry with melanoma-associated monoclonal antibodies in choroidal melanoma: a comparison of the clinical and immunohistochemical results.

Authors:  D F Schaling; J P van der Pol; M J Jager; M J van Kroonenburgh; J A Oosterhuis; D J Ruiter
Journal:  Br J Ophthalmol       Date:  1990-09       Impact factor: 4.638
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.